Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings. (Q45928710)
Jump to navigation
Jump to search
scientific article published in September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings. |
scientific article published in September 2009 |
Statements
1 reference
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings. (English)
1 reference
1 reference
Antonella d'Arminio Monforte
1 reference
EuroSIDA Study Group
1 reference
Bonaventura Clotet
1 reference
Andrzej Horban
1 reference
Andrew N Phillips
1 reference
Ann-Brit Eg Hansen
1 reference
Johann Bruun
1 reference
1 September 2009
1 reference
200
1 reference
5
1 reference
687-697
1 reference
Identifiers
1 reference
1 reference